Molecular docking suggests repurposing of brincidofovir as a potential drug targeting SARS-CoV-2 ACE2 receptor and main protease.
Mostafa A HussienAhmed E M AbdelazizPublished in: Network modeling and analysis in health informatics and bioinformatics (2020)